pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 1
    VIR-5500
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$VIR Vir Biotechnology, Inc.
  • Phase 1
    VIR-5525
    Adenocarcinoma$VIR Vir Biotechnology, Inc.
  • Phase 1
    VIS-171
    Autoimmune Disorders Visterra Inc
← prev
page 146 of 231
next →
131
Pain89
Neurology1
Phase 1
VIS-954
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculiti…
Visterra Inc
  • Preclinical
    VIS-DerMap
    Basal Cell Carcinoma (Basal Cell Epithelioma) ArrayPatch Ltd
  • VISINE ALLERGY EYE RELIEF MULTI-ACTION
    VISINE ALLERGY EYE RELIEF MULTI-ACTION (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)
    no indication KENVUE BRANDS
  • VISIONBLUE
    VISIONBLUE (TRYPAN BLUE)
    no indication DORC
  • VITRAKVI
    VITRAKVI (LAROTRECTINIB)
    no indication BAYER HLTHCARE
  • Phase 1
    VK-0214
    Adrenomyeloneuropathy (AMN)$VIK Viking Holdings Ltd
  • Phase 2
    VK-5211
    Bone Fracture$VIK Viking Holdings Ltd
  • Phase 2
    VL-PX10 + VL-P22
    Coronavirus Disease 2019 (COVID-19) Associated Acute Resp… Vitti Labs LLC
  • Phase 3
    VLA-15
    Lyme Disease$VALN Valneva SE
  • Phase 2
    VLP-001
    Peanut Allergy Allergy Therapeutics Plc
  • Phase 2
    VLPM-01
    Malaria VLP Therapeutics LLC
  • Phase 2
    VLS-1488
    Ovarian Cancer Volastra Therapeutics Inc
  • Phase 1
    VMPAIN-004
    Complex Regional Pain Syndrome (Sympathetic Reflex Dystro… Vivamed BioPharma
  • Phase 2
    VMPSY-002
    Substance (Drug) Abuse Vivamed BioPharma
  • Phase 2
    VMPSY-003
    Opium (Opioid) Addiction Vivamed BioPharma
  • Phase 2
    VMT-01
    Metastatic Melanoma$CATX Perspective Therapeutics, Inc.
  • Phase 2
    VMT-a-NET
    Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)$CATX Perspective Therapeutics, Inc.
  • Preclinical
    VNLG-152
    Triple-Negative Breast Cancer (TNBC) Isoprene Pharmaceuticals Inc
  • Preclinical
    VNRX-6355
    Neisseria gonorrhoeae Infections VenatoRx Pharmaceuticals Inc
  • Phase 2
    VNX-101
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla… Vironexis Biotherapeutics Inc
  • Phase 2
    VNX-202
    Gastric Cancer Vironexis Biotherapeutics Inc
  • Phase 2
    VP-001
    Retinitis Pigmentosa (Retinitis) PYC Therapeutics Ltd
  • Preclinical
    VPD-380
    Pulmonary Arterial Hypertension Corsair Pharma Inc
  • Phase 2
    VR-101
    Female Contraception VaRi Bioscience GmbH
  • Phase 2
    VR-103
    Endometriosis VaRi Bioscience GmbH
  • Preclinical
    VRG-145
    Migraine VRG Therapeutics Ltd
  • Preclinical
    VS-01
    Hyperammonemia Genfit SA